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Perinatal asphyxia
Definitions
The term hypoxia is used when oxygen deficiency results in altered or impaired tissue 
energy metabolism. Ischemia means diminished blood supply to an organ or tissue. 
Asphyxia is defined as a condition of impaired gas exchange, either through the placenta 
or the lungs, leading to progressive hypoxemia (low partial pressure of oxygen in the 
blood), hypercapnia (high partial pressure of carbon dioxide in blood) and metabolic 
acidosis, the latter being due to insufficient tissue oxygen supply leading to an anaerobic 
metabolism with  production of lactate. However, according to the ACOG committee ( 
2004), the clinical term birth asphyxia is a nonspecific diagnosis that should not be used 
and a neonate who has had hypoxia proximate to delivery severe enough to result in 
hypoxic-ischemic encephalopathy (HIE) will show other signs of hypoxic damage, 
including all of the following:
x Metabolic acidosis in foetal umbilical cord arterial blood obtained at delivery  
 (pH <7 and base deficit 12 mmol/L). 
x Apgar scores of 0-3 for beyond 5 minutes.  
x Evidence of neonatal neurological sequelae (e.g. seizures, coma, hypotonia).  
x One or more of the following organ or system injuries; cardiovascular, 
pulmonary, gastrointestinal, haematological, hepatic or renal.
Epidemiology 
Approximately 4 million infants out of 130 million worldwide annual births suffer from 
birth asphyxia. Of these, approximately 25% die and 25% develop some kind of 
neurological sequelae (UNICEF 2003). In the western part of the world, 2-6/1000 
develop HIE (Levene et al. 1985). While there has been a dramatic reduction in under-
five mortality in the past two decades, there has been relatively little change in newborn 
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mortality (Bhutta et al. 2005), and newborn deaths now constitute over 40% of all deaths 
in children aged  below five years (Bryce et al. 2005). Reducing neonatal mortality may 
thus be critical for reaching the millennium development goal 4 target of a two-third 
reduction in deaths among children under five years of age. The number of disability-
adjusted life years (DALYs) for birth asphyxia estimated by WHO exceed those due to 
all childhood conditions preventable by immunization. In addition, asphyxia at birth is 
the most common cause of neurodevelopmental handicap occurring in full-term infants as 
a result of a perinatal insult (Levene et al. 1985;Volpe 2001). 
Risk factors, pathophysiology and mechanisms
HIE can have different causes, as Badawi et al found 70% of all term infants to show HIE 
without preceding asphyxia (Badawi et al. 1998). Interruption of blood or oxygen supply 
to the foetus can be caused by maternal factors (hypotension, pre-eclampsia, uterine 
tetany or rupture), by placental or umbilical cord  factors (abruption, infection, 
inflammation, umbilical cord compression or occlusion) or postnatally due to diseases in 
the infant (severe respiratory distress syndrome, recurrent apnoeic spells, CNS 
depression, anomalies or infection) (Nelson 2003;Volpe 2001). The foetal response leads 
initially to an increase in cerebral blood flow (Jensen et al. 1991;Lehnardt et al. 2003). 
However, as a result of asphyxia, impairment of cerebral auto regulation occurs, resulting 
in a linear relationship between blood pressure and cerebral blood flow, leaving the brain 
vulnerable to damage when blood pressure fluctuates (Fenichel 1983;Volpe 2001). 
Eventually, cardiac output is reduced, leading to systemic hypotension and a decrease in 
cerebral blood flow (Volpe 2001). The foetus is then at risk of developing multiple organ 
damage, including brain damage. The hypoxic-ischemic brain damage in full-term or 
post-term infants is clinically seen as HIE, while in pre-term infants the clinical findings 
are more unspecific due to the immaturity of the CNS (Tapia-Rombo et al. 2000). 
At the cellular level, cerebral hypoxia-ischemia (HI) initiates a cascade of biochemical 
events starting with a shift from oxidative to anaerobic metabolism due to insufficient 
tissue oxygen supply (Calvert et al. 2005;Inder et al. 2000). Anaerobic metabolism results 
in the accumulation of reduced nicotinamide-adenine-dinucleotide (NADH) and flavin-
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adenine-dinucleotide (FADH) and lactic acid, eventually causing metabolic acidosis. 
Anaerobic glycolysis cannot maintain the cellular energy demands, resulting in a 
depletion of high-energy phosphate reserves, including ATP. HI stimulates the release of 
excitatory amino acids, including glutamate, activating glutamate cell-surface receptors, 
resulting in an influx of Na+ and Ca2+. Ca2+-ions also accumulate as a consequence of its 
release from mitochondria and endoplasmic reticulum. In addition, energy-requiring 
transcellular ion pumping fails, leading to the accumulation of intracellular Na+, Cl-,
Ca2+, and water (cytotoxic edema). Within the cytosol, free fatty acids accumulate from 
an increased membrane phospholipid turnover and undergo peroxidation by oxygen-free 
radicals that arise amongst others from mitochondrial metabolism and as by-products in 
the synthesis of prostaglandins, (hypo-) xanthine and uric acid. Moreover, nitric oxide, a 
free-radical gas, is generated via Ca2+-activation of nitric oxide synthase in selected 
neurons and diffuses to adjacent cells that are susceptible to nitric oxide toxicity. The 
combined effects of cellular energy failure, acidosis, glutamate, Ca2+ accumulation, free-
radical formation, lipid peroxidation and nitric oxide neurotoxicity serve to disrupt 
structural components of the cell resulting in its ultimate death.
Hypoxic-ischemic encephalopathy  
The hypoxic-ischemic brain damage in full-term or post-term infants is clinically seen as 
HIE (Tapia-Rombo et al. 2000). HIE has been classified into three grades, and the 
severity of HIE is a very useful predictor of long-term outcome in asphyxiated newborn 
infants (Fenichel 1983;Levene et al. 1985;Sarnat et al. 1976). A simplified grading could 
be:
x Mild/grade I: irritability (“hyperalert”), mild hypotonia and poor sucking. 
x Moderate/grade II: lethargic, seizures, marked abnormalities of tone and requires 
tube feeding.
x Severe/grade III: comatose, prolonged seizures, severe hypotonia and failure to 
maintain spontaneous respiration.
Grade I is associated with good outcome, grade III with severe handicap or death in 
almost all infants, while grade II carries a poor prognosis in 15-30% of all infants. The 
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determination of the severity of an asphyxial exposure is difficult. Although evidence of a 
significant metabolic acidosis can establish that exposure to hypoxia has occurred, it does 
not necessarily reflect the severity, the duration or the nature of the asphyxial exposure 
(i.e., continuous or intermittent), whether the asphyxia during labour and delivery is the 
last of a series of episodes or the characteristics of the fetal cardiovascular response (Low 
1997). The determination of the short-term outcome, as expressed by neonatal HIE and 
organ system complications, provides both an indicator of the severity of an asphyxial 
insult (classified into mild, moderate or severe, table 1), and criteria for the prediction of 
the long-term outcome (Low 1997).  
Asphyxia
Metabolic
acidosis at 
delivery* 
Encephalopathy
Cardiovascular,
respiratory, and  
renal complications 
Minor Moderate Severe Minor Moderate/Severe
Mild + ±   ±  
Moderate +  +   ± 
Severe +   +  + 
*Umbilical artery base deficits 12 mmol/L. 
Table 1: Classification of intrapartum fetal asphyxia, in mild, moderate and severe 
(Low et al. 1997). 
Treatment  
The cascade of deleterious events leading to cell death appears to continue also after the 
termination of a hypoxic-ischemic insult, and is named “delayed” cell death (Fellman et 
al. 1997;Wyatt et al. 1989). This gives the possibility of a beneficial intervention during 
this “therapeutic time window”. However, as postulated by Gluckman et al, we should 
view the perinatal period as a vulnerable one, in which an asphyxial injury does not lead 
to a set outcome and where a variety of physiological factors impact on the developing 
brain (Gluckman et al. 2001).  
Although many  interventions have proven beneficial in animal studies, even when begun 
in the first hours of reperfusion, only a few appear to be relatively safe clinically and 
likely to be useful for protection of both neurons and oligodendroglia. Possible 
intervention-strategies in the prevention or amelioration of perinatal HI brain injury are: 
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Decrease energy depletion (hypothermia, barbiturates, mild hypercapnia), inhibit 
glutamate release (calcium channel blockers, magnesium, adenosine/adenosine agonists, 
hypothermia, free radical scavengers), block glutamate receptors [N-methyl-D-aspartate 
(NMDA) receptor antagonists (MK-801, magnesium, ketamine) and non-NMDA receptor 
antagonists (NBQX, CNQX)], inhibit leukocyte-microglial-cytokine effects (neutropenia, 
anticytokine antibodies, IL-1 receptor antagonists) and blockade of downstream 
intracellular events (hypothermia, free radical synthesis inhibitors, free radical 
scavengers, NOS inhibitors-scavengers and antiapoptotic agents). 
Amongst these, only mild hypothermia seems to improve the outcome after perinatal 
asphyxia both in animal experiments (Bona et al. 1998;Thoresen et al. 1995;Tooley et al. 
2003) and in clinical studies (Eicher et al. 2005;Gluckman et al. 2005;Shankaran et al. 
2005). The mechanisms of this effect are still somewhat uncertain. A reduction in 
temperature slows down cerebral metabolic rate and reduces energy demand (Erecinska 
et al. 2003;Laptook et al. 1995). However, the major neuroprotective effect of post-insult 
hypothermia seems related to the suppression of mechanisms and cascades responsible 
for delayed energy failure and delayed cell death hours after the insult. Among the 
observed findings are a reduced inflammatory response, preventing inflammatory cell 
activation and reduced infiltration to the ischemic brain (Wang et al. 2002b), as well as a 
decreased nuclear factor țB (NF-ƸB) activity (Yenari et al. 2006). Also a reduced release 
of NO and excitotoxins is seen (Thoresen et al. 1997) as well as a reduced generation of 
free oxygen radicals (Lei et al. 1997;Si et al. 1997). Furthermore, post-ischemic 
hypothermia  attenuates damage to mitochondrial function (Canevari et al. 1999), and 
interferes with apoptotic pathways (Pabello et al. 2005;Van et al. 2003). The incidence of 
serious adverse events in clinical studies was similar in hypothermia and control groups 
(Eicher et al. 2005;Gluckman et al. 2005;Shankaran et al. 2005). However, a recent 
Cochrane review, consisting of eight randomised controlled trials comprising 638 term 
infants, found an increase in the need for ionotrope support of borderline significance and 
a significant increase in thrombocytopenia (Jacobs et al. 2007). Mild therapeutic 
hypothermia is now considered to be safe in an intensive care setting, and is introduced in 
many countries (Azzopardi et al 2008), including Norway. The current criteria for 
hypothermia treatment at Rikshospitalet University Hospital are gestational age  36 
14 
weeks, no signs of serious malformations, and at least one out of; Apgar  5 at 10 min, 
pressure ventilation necessary at 10 min or pH <7.00 or BE < -16 mmol/L within 60 min 
after birth. In addition, the infant must have moderate to serious encephalopathy with 
symptoms of changed consciousness, and at least one out of; musclehypotonia, 
pathological reflexes of tendon, eye movement or pupil, weak or missing sucking reflex 
or seizures.
A recent systematic review in BMJ Clinical evidence studied the effects of interventions 
in term or near-term newborns with perinatal asphyxia (McGuire 2006). They found 
limited evidence from three small, weak RCTs suggesting that mortaliy may be lower in 
infants treated with antioxidants compared with placebo (Benders et al. 2006;Gunes et al. 
2007;van et al. 1998). Further, limited evidence from one small RCT suggested that a 
magnesium sulphate/dopamine combination may be more effective than no treatment in 
reducing a combined outcome of mortality, abnormal scans, and failure to feed (Ichiba et 
al. 2002). Small RCTs with flawed methods suggested that anticonvulsants are of no 
benefit in reducing mortality or improving neurodevelopmental outcomes (Evans et al. 
2007;Singh et al. 2005). Recent meta-analyses show that mortality is lower in newborn 
infants resuscitated with room air compared to 100% oxygen (Rabi et al. 2007;Saugstad 
et al. 2005b;Tan et al. 2005). Finally, they were not able to conclude on whether calcium 
channel blockers (Levene et al. 1990), corticosteriods (Alderson et al. 2005;Altman et al. 
1984), fluid restriction (Kecskes et al. 2005), hyperventilation (Rosenberg 1992), 
inotrope support (Hunt et al. 2002), mannitol (Adhikari et al. 1990), or opiate antagonists 
(McGuire et al. 2004) are helpful in infants with perinatal asphyxia.
To conclude, there is currently evidence of a beneficial effect mainly of therapeutic 
hypothermia in term newborns with HIE (Jacobs et al. 2007). 
Acidosis
During HI, anaerobic metabolism due to insufficient tissue oxygen supply results in two, 
instead of 38, mol ATP per mol glucose. The subsequent production of lactate causes 
both extracellular and intracellular acidosis. The acidosis continues for a few hours after 
the oxygen supply to the tissue has been re-established (Saugstad et al. 2005a) and it can 
have multiple effects on the neuronal tissue, both protective and detrimental. During an 
15 
asphyxial episode, acidosis (accumulation of acid in the tissue) is not synonymous with 
acidemia (accumulation of acid in the blood). Infants with clinical acute birth asphyxia 
can be born without acidemia. It has been suggested that these non-acidemic, asphyxiated 
infants, who are not able to establish a “beneficial acidemia”, are at an increased risk of 
brain injury compared to infants with mild or moderate acidemia (pH 7.0-7.2) 
(Hermansen 2003).  
The beneficial effect of a mild to moderate acidosis can be explained by decreased 
cerebral oxidative metabolism (Richardson 1993), a shift in the oxygen dissociation curve 
to the right (the Bohr effect) promoting oxygen unloading in the tissues (Hermansen 
2003) and protection against ischemic injury in the developing heart (Iannettoni et al. 
1992). Acidosis act also protective through inhibition of NMDA-mediated calcium 
currents (Giffard et al. 1990;Tombaugh et al. 1990), through reducing kainate-mediated 
damage (Giffard et al. 1990) and through inhibition of NO-synthase (Anderson et al. 
2000).
These beneficial, protective effects of a mild to moderate acidosis can be lost in the case 
of a severe acidosis, which causes decreased myocardial contractility and diminished 
cardiac output (Downing et al. 1966), directly contributing to cerebral ischemia. When 
pH falls below 7.0, the infant is placed at a substantially increased risk of developing 
long-term cerebral damage (Andres et al. 1999). Acidosis can be detrimental through 
increasing lipid peroxidation (Siesjo et al. 1985), exacerbation of oxidative injury by 
impairing antioxidant enzyme functions and increasing intracellular free iron levels 
(Buonocore et al. 1998;Buonocore et al. 2003), as well as the release of iron from ferritin 
and increasing the pool of low molecular weight iron (Bralet et al. 1992). Acidosis can 
also be detrimental through aggravating AMPA-receptor-mediated cell damage 
(McDonald et al. 1992), inhibiting astrocyte glutamate reuptake (Swanson et al. 1995) 
and by activating human neutrophils, delaying neutrophil apoptosis and extending 
neutrophil functional lifespan (Trevani et al. 1999). In our NT2-N neurons, we have 
shown that the effect of acidosis on neuronal survival is dependent on the timing of 
acidosis, as acidosis was protective during oxygen-glucose deprivation and detrimental 
during reoxygenation (Almaas et al. 2003;Froyland et al. 2005).
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Mitochondrial dysfunction and secondary energy failure 
The mitochondrial electron transport chain (ETC) completes the oxidation of fuel 
molecules by oxygen and the concomitant energy transduction into ATP via five 
complexes embedded in the inner mitochondrial membrane (Munnich et al. 2001). 
Mitochondrial DNA encodes 13 out of the > 80 subunits of the ETC, while nuclear DNA 
encodes the remaining majority (Enns 2003). Studies provide evidence that mitochondrial 
respiratory capacity is impaired during both global and focal ischemia (Blomgren et al. 
2006;Hagberg 2004;Kuroda et al. 1996;Nakai et al. 1997;Nelson et al. 1994). This 
impairment is seen as a decrease in ADP-stimulated and uncoupled respiratory rates, due 
mainly to a decrease in the activity of complex I, II-III and V, while complex IV activity 
is unaffected by graded cerebral ischemia (Allen et al. 1995). Substantial recovery of 
mitochondrial function often occurs during the first hours of reperfusion, however it may 
deteriorate again as reperfusion is continued (Almeida et al. 1995;Anderson et al. 
1999;Folbergrova et al. 1995;Kuroda et al. 1996;Li et al. 2000;Nakai et al. 1997;Wagner 
et al. 1990a;Wagner et al. 1990b). This dysfunction may reflect an inhibition of one or 
several of the complexes or a more general “mitochondrial inhibition”. Decreased activity 
of complex II and IV in hyperglycemic cats (Wagner et al. 1990a) and of complex IV in 
gerbils (Almeida et al. 1995) has been demonstrated during reoxygenation following 
transient ischemia. Since ischemia per se gives rise to a decrease in complex I, II-III and 
V activities (Allen et al. 1995), it has been postulated that recirculation triggers damage 
to complex IV, which needs a complete boundary layer of phospholipids, susceptible to 
peroxidation, for full activity (Almeida et al. 1995).  
This “delayed” damage can be due to recirculation-enhanced production of reactive 
oxygen species (ROS), causing membrane damage or enzyme inactivation due to lipid 
peroxidation and/or protein oxidation (Floyd et al. 1992). Delayed treatment with the free 
radical spin trap Į-Phenyl-N-tert-butyl nitron (Folbergrova et al. 1995;Kuroda et al. 
1996) and NXY-059 (Yoshimoto et al. 2002) prevents secondary energy failure, strongly 
indicating that free radicals play an important role in recirculation-induced injury (Floyd 
et al. 1992). Also, the immunosuppressant drugs FK506 (Nakai et al. 1997) and 
Cyclosporin A (Li et al. 2000) ameliorate secondary mitochondrial dysfunction through 
an effect on mitochondrial permeability transition (MPT). The mitochondrial ETC has 
17 
been recognized as one of the major cellular generators of ROS. When the ETC is 
damaged or inhibited, the production of ROS may increase (Enns 2003), therefore 
contributing to the ROS generated during ischemia and reperfusion (Blomgren et al. 
2006). The sites of ROS production in the mitochondria are believed to be ubiquinone of 
complex III and the FMN group of complex I (Liu et al. 2002). Electrons leak out to 
molecular oxygen forming superoxide, which is quickly converted to H2O2 by the 
mitochondrial superoxide dismutase (Liu et al. 2002). On the other hand, free radicals 
may also damage the mitochondria, although the precise mechanisms remain to be 
clarified.
Ischemia, together with e.g., free radicals, high calcium and neurotoxins may also affect 
the mitochondria in another way, as these factors can affect the formation of the MPT 
pore. MPT is a sudden permeability increase of the inner mitochondrial membrane to 
solutes  1.5 kDa (Kroemer et al. 1997;Maciel et al. 2001). MPT opening causes an 
uncoupling of the ETC with the collapse of the mitochondrial transmembrane potential 
and cessation of ATP synthesis, matrix Ca2+ outflow, generation of ROS and release of 
apoptogenic proteins such as apoptosis-inducing factor (Kroemer et al. 1997;Li et al. 
2000;Zhu et al. 2007). Both depolarization and increased permeability of the outer 
membrane have been suggested as a possible mechanism for cytochrome c release, but 
whether mitochondrial depolarization is a prerequisite for apoptosis, is debated. While 
staurosporine-induced apoptosis in rat hippocampal neurons involves both release of 
cytochrome c and activation of caspases-3, there is no requirement for mitochondrial 
depolarization (Krohn et al. 1999). Recently, it was suggested that different phenotypes 
of cell death, varying from cell to cell, is dependent on the energy available to drive the 
apoptotic pathways to completion  (Northington et al. 2007).  
Inflammation  
Inflammation is a general term used to describe the many diverse processes that tissues 
employ in response to infection, injury, or insult of any kind. The initial phase of 
inflammation was described by Celsus (about 30 BC-38 AD) by four cardinal signs: 
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rubor (redness), tumor (swelling), dolor (pain), and calor (heat). Later, Virchow (1821-
1902) added the fifth, functio laesa (loss of function).
Acute inflammation is initiated by the release of inflammatory mediators, comprising 
among others the products of coagulation, fibrinolysis, the complement system, 
cytokines, and oxygen derived free radicals (Gilroy et al. 2004). Within seconds after the 
injury, there is increased blood flow and leakage of fluid into the surrounding tissue, due 
to dilated capillaries and increased capillary permeability, respectively. Neutrophils, 
macrophages and mast cells belonging to the “first line defence” (innate immunity), 
infiltrate through adhesion and migration. Recognition of pathogen associated molecular 
patterns on micro-organisms by e.g. complement receptors, scavenger receptors and toll-
like receptors results in phagocytosis and elimination of invading pathogens and/or repair 
of the injured tissue. In addition, T and B lymphocytes (adaptive immunity), proliferate 
clonally and respond highly specifically to antigenic determinants of specific pathogens.  
Similar responses to infection, injury, or insult of any kind are known to occur in the 
CNS. However, tight junctions between endothelial cells of the blood brain barrier limit 
access of peripheral immune cells to the brain, making it generally an immune privileged 
tissue. In the brain, inflammation is characterized by restricted infiltration of leukocytes, 
activation of resident cells (e.g., microglia, astrocytes and endothelial cells) and local 
production of cytokines (Allan et al. 2003). 
Inflammation probably plays a significant role in perinatally acquired brain damage, both 
as a cause in it self and as a contributing mechanism during HI (Greenwood et al. 
2005;Hagberg et al. 2002). Both animal experiments and epidemiological studies indicate 
that if the perinatal brain is exposed to both inflammation and HI, the damaging effect 
increases markedly (Figure 1) (Eklind et al. 2001;Hagberg et al. 2002;Kendall et al. 
2005;Nelson et al. 1998). Inflammatory mediators may therefore represent a "final 
common pathway" for both infectious and HI brain damage (Shalak et al. 2002b).
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Figure 1: Putative relationship between 
brain injury, antepartum 
inflammatory activation and 
intrapartum HI stress. Foetus A can 
withstand substantial intrapartum stress 
before permanent injury is initiated. 
Foetus B will develop permanent injury 
as a result of antepartum infection 
despite minimal intrapartum stress. 
Foetus C is vulnerable to intrapartum 
stress and will escape permanent injury 
provided that the ischemic threshold is 
not reached. Adapted from (Kendall et al. 
2005) with permission from Blackwell 
Publishing.
A causal relationship between inflammation and brain damage was strengthened by 
animal experiments where induction of perinatal inflammation, for example by injecting 
lipopolysaccharide (LPS) leads to brain damage (Eklind et al. 2001). Epidemiological 
studies show a correlation between markers of inflammation like chorioamnionitis and 
cerebral palsy (Grether et al. 1997;Wu et al. 2000). On the other hand, HI can lead to 
inflammation, as increased level of cytokines are found in the plasma of newborn infants 
after hypoxia (Silveira et al. 2003). Several studies suggest that cytokines can be 
produced in situ rather than being transported into the brain from the systemic circulation 
(Cai et al. 2000;Kadhim et al. 2001;Saito et al. 1996). After HI, high levels of interleukin 
(IL)-6 and tumor necrosis factor (TNF)-Į have been found in CSF of newborn infants 
(Silveira et al. 2003). Elevations after HI were also found in brain sections from rat of IL-
1ȕ and TNF-Į (Bona et al. 1999), IL-1Į, IL-1ȕ and IL-6 (Hagberg et al. 1996), IL-18 
(Hedtjarn et al. 2002) and MIP-1Į (Cowell et al. 2002), and of IL-1ȕ, IL-6 and TNF-Į in 
gerbils (Saito et al. 1996).
Cytokines and chemokines 
Cytokines are a heterogeneous group of naturally-produced proteins, consisting among 
others of chemokines, interleukins, inflammatory cytokines, interferons and 
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hematopoietic growth factors. Although cytokines are produced predominantly by cells 
of the immune system, there are a number of reports showing the presence of cytokines in 
the CNS (Bakhiet et al. 2002;Cai et al. 2000;Coughlan et al. 2000;Ellison et al. 
2005;Kadhim et al. 2001;Mousa et al. 1999;Savman et al. 1998).  
Chemokines, a type of cytokines, are small (8-14 kDa), mainly basic, molecules which 
are structurally and functionally related to form a family of proteins. They were first 
discovered in 1987, and there are now more than 50 chemokines that interact with at least 
20 receptors. Based on the position of their first N-terminal cystein residue, chemokines 
are subdivided into four groups; the CXC (Į-chemokines), the CC (ȕ-chemokines), the 
CX3C (į-chemokines) and the C (Ȗ-chemokines) (Figure 2). Chemokines are produced in 
the CNS in neurons, astrocytes, microglia, oligodendrocytes and endothelial cells (Dorf et 
al. 2000;Gebicke-Haerter et al. 2001). 
Figure 2: Chemokine receptor classification and ligand specificity. The four groups of 
chemokines; CXC, CC, CX3C and C with their members, and the four classes of 
chemokine receptors; CXCR, CCR, CX3CR and XCR. Adapted from (Bajetto et al. 2001) 
with permission from Elsevier. 
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Receptors 
Cytokines initiate their actions by binding to specific surface receptors on target cells. 
These receptors exhibit high affinities for their ligand, and very small amounts of 
cytokines can elicit a cascade of intracellular signals that result in a particular cellular 
response (Wang et al. 2002a). For example, IL-1 binds to IL-1R1 (Andre et al. 
2005;Friedman 2001) and activates two distinct signalling pathways, resulting in the 
activation of NF-țB and the mitogen-activated protein kinases (MAPKs) extracellular 
signal-regulated protein kinase (ERK1/2) p38 and c-jun N-terminal kinase (JNK) (O'Neill 
et al. 1998). IL-6 acts by binding to its high affinity receptor IL-6R (gp80), soluble or cell 
bound, which results in signal transduction via the JAK/STAT system (Heinrich et al. 
1998). IL-10 activity is mediated by its specific cell surface receptor complex, IL-10/IL-
10R, resulting essentially in transcriptional activation of several hundred genes, probably 
through inhibition of NF-țB (Asadullah et al. 2003).
Chemokines exert their activity by binding to surface bound transmembrane G protein-
coupled receptors (Nguyen et al. 2001), often through interactions with sulphated 
proteins and proteoglycans (Bajetto et al. 2002). Chemokine receptor nomenclature is 
based on the chemokine group to which their ligand(s) belong, since the chemokine-
chemokine receptor interactions are almost always restricted within a single subclass 
(Bajetto et al. 2002). So far, six CXC receptors (CXCR1 to CXCR6), 11 CC receptors 
(CCR1 to CCR11) and a single receptor for fractalkine (CX3CR1) and lymphotactin Į/ȕ
(XCR1) have been identified (Figure 2, (Bajetto et al. 2002)).
A large number of chemokine receptors are expressed either constitutively or induced by 
inflammatory mediators on neurons, astrocytes, microglia, and oligodendrocytes, and 
they are found in humans, macaque, mouse and rat (Bajetto et al. 2002). The most 
characteristic response, stimulation of cell migration, appears to require functional 
coupling of the receptor to GĮi, resulting in a rapid activation of phospholipase C, 
inositol-1,4,5-triphosphate generation and a transient elevation of cytosolic Ca2+-
concentrations (Bajetto et al. 2002). Also, regulation of other ion fluxes after chemokine 
receptor activation has been described (Hegg et al. 2000;Liu et al. 2000).  
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Function
Cytokines function as mediators of intercellular communication, as they regulate cell 
function during development and maintain homeostasis in the mature organism and 
during defence-responses to infection and inflammatory, autoimmune, traumatic, and 
ischemic injury (Wang et al. 2002a). Cytokines can be both proinflammatory (e.g., IL-1 
and IL-6) and antiinflammatory (e.g., IL-10). Whether cytokines associated with the 
inflammatory response are neuroprotective or detrimental, depends on the type of 
cytokine, timing, conditioning and the presence of other molecules (Nelson et al. 2002a).  
Chemokines were initially recognized to control immune cell trafficking and recirculation 
by stimulating target-cell-specific directional migration of leucocytes (Baggiolini 1998), 
the hallmark being their ability to stimulate directed migration of cells toward a chemical 
gradient (Dorf et al. 2000). Stimulation of their receptors leads to diverse responses, and 
despite structural similarity and apparent redundancy, the chemokine receptors differ in 
their capacity to activate signal transduction pathways (Bajetto et al. 2002). In addition to 
playing a fundamental role in immune system function and homeostasis, chemokines are 
also shown to be important in angiogenesis, tumor and metastasis progression and in the 
CNS (Bajetto et al. 2001;Bajetto et al. 2002;Tran et al. 2003). However, the roles for 
chemokines in neuronal development and in fetal and neonatal CNS inflammation are 
largely unknown (Coughlan et al. 2000;Nguyen et al. 2001). As discussed previously, 
chemokines play a crucial role in the leukocyte accumulation into ischemic lesions, 
making their receptors potential targets for therapeutic intervention after ischemia 
(Minami et al. 2005).  
The complement system 
The complement system, first described over a century ago, comprises >30 proteins in 
plasma and on cell surfaces. It is part of the host defence response, and acts in a specific 
manner to protect the host against invading organisms and to bridge in the interface 
between innate and adaptive immunity (Mollnes et al. 2002;Walport 2001). Killing of 
pathogens is the crucial effect of the complement system, done mainly by opsonization of 
pathogens, leading most often to phagocytosis. The complement system consists of three 
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different pathways (Figure 3); the classical (a), the lectin (b), and the alternative (c) 
pathway, depending on initiators and downstream activation of the different systems. 
Figure 3: The complement system, schematic presentation. Adapted from (Mollnes et al. 
2002) with permission from Elsevier. 
The classical pathway is activated when antibodies bind antigen, and occasionally also 
by non-antibody mechanism (e.g. C-reactive protein). Activated C1q triggers the serine 
proteases C1r and C1s, the latter cleaving first C4 to C4a, which binds C2, and then C2 to 
C4b2a (C3 convertase). C3 convertase cleaves C3 to C3a and C3b. The lectin pathway is 
activated when microbes with terminal mannose groups are recognized by mannose-
binding lectin (MBL). MBL is homologous to C1q and triggers MBL-associated serine 
proteases (MASPs). Downstream activation of the lectin pathway is virtually identical to 
classical-pathway activation. The alternative pathway is activated by different bacteria, 
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fungi, viruses and tumours which hydrolyze C3, leading to binding of factor B and 
formation of C3 convertase [(C3(H2O)Bb)]. The three pathways merge at the common 
pathway of the complement system with activation of C3 and C5, leading to the terminal 
pathway activation with C5a and TCC as final products.
Complement activation is regulated strictly by inhibitory proteins, and there are as many 
regulators as ordinary components of the cascade. Deficiency of any of the regulatory 
proteins is associated with substantially disturbed homeostasis and serious conditions 
(Mollnes et al. 2002). The membrane regulators complement receptor 1 (CR1/CD35), 
membrane cofactor protein (MCP/CD46) and decay accelerating factor (DAF/CD55) 
regulate complement activation by acting as cofactors for factor-I-mediated cleavage of 
C4b and C3b (CR1 and MCP), or accelerating the decay of the C3 and C5 convertases 
(CR1 and DAF). Protectin (CD59), also a membrane regulator, prevents the binding of 
C9 to the C5b-8 complex in the terminal pathway.  
Hypoxia regulated gene-expression 
Hypoxia alters the expression of several genes through both transcriptional activation and 
post-transcriptional mechanisms. Genes that become activated are taking part in 
intracellular metabolic adaptations to hypoxia, e.g., transcription factors (e.g., hypoxia 
inducible factor 1 (HIF-1), activator protein 1 (AP-1) and NF-țB), glucose transporters 
and glycolytic enzymes. Also, genes encoding factors acting locally to save hypoxic 
tissue, e.g., vascular endothelial permeability growth factor, and factors affecting the 
entire organism, e.g., erythropoietin and tyrosine hydroxylase, are activated.
HIF-1 is an oxygen-regulated transcription factor that functions as a master regulator of 
oxygen homeostasis (Semenza 2001). It is a heterodimer composed of HIF-1Į and HIF-
1ȕ (Semenza 2001). Whereas HIF-1ȕ is constitutively expressed, HIF-1Į expression is 
induced upon decreases in oxygen tension. Upon removal of a normoxic-induced 
degradation, an exponential increase in expression occurs when the cells are subjected to 
decreasing oxygen concentrations (Jiang et al. 1996). HIF-1Į translocates to the nucleus 
where it dimerizes with HIF-1ȕ; this complex binds to hypoxia-responsive elements 
(HRE) in the promoters of target genes and activates their transcription (Eguchi et al. 
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1997;Pollenz et al. 1994). Several dozen HIF-1 regulated target genes have been 
identified that play essential roles in cellular and systemic responses to hypoxia, 
including glycolysis, erythropoiesis, angiogenesis and vascular remodeling (Semenza 
2000;Willam et al. 2006), the main goal of these is to facilitate cell survival (Greijer et al. 
2005).
AP-1 is a transcription factor made up of Fos- and Jun-related protein dimers (c-Fos, 
FosB, Fra1, Fra2, c-Jun, junB, and junD). It transduces signals from biological mediators 
(e.g., cytokines, growth factors and neurotransmitters) to stress-response genes by 
binding to their response elements. AP-1, together with NF-țB, are examples of early-
response genes encoding transcription factors that couple changes in ambient levels of 
intercellular biological signal molecules (e.g., cytokines and growth factors) or genotoxic 
signals (e.g., free radicals) to specific and coordinated patterns of gene expression. 
Activator proteins play a complex role in the modulation of apoptosis (Tong et al. 1998) 
and ischemia causes an increase in AP-1 proteins. 
The transcription factor NF-țB is a key regulator of inflammation and cell survival. It 
consists of five subunits; p50, p52, p65 (RelA), RelB, and c-Rel, forming homo- and 
heterodimers (Zhang et al. 2005). In the inactive state, NF-țB dimers are sequestered in 
the cytoplasm by the specific inhibitors IțB (Į, ȕ and Ȗ). NF-țB can be activated in cells 
by a variety of stimuli, including glutamate, endotoxin, ROS, TNF-Į, IL-1ȕ, mitogens, 
viral proteins, ionizing radiation, UV light, and certain chemical agents (Blackwell et al. 
1997;Cheah et al. 2005;Scholzke et al. 2003;Siebenlist et al. 1994). On stimulation, IțB
is phosphorylated by the IțB kinase (IKK) complex, ubiquitinated, and degraded by the 
26S proteasome. In addition, there are also pathways of NF-țB activation that are 
independent of IKK or the proteasome (Scholzke et al. 2003). When the IțB inhibition 
has been removed, the NF-țB dimer (p50/p50 or p50/p65) translocates to the nucleus and 
binds to specific promoter sites. This results in the transcription of an array of genes, 
including those for proinflammatory cytokines and chemotactic factors that drive and 
amplify the inflammatory response, e.g., cytokines (TNF-Į, TNF-ȕ, IL-1ȕ, IL-6, IL-8, 
monocyte chemoattractant protein-1 (MCP-1), MIP-1, Regulated on activation normal T 
cell expressed and secreted (RANTES), IFN-ȕ, G-CSF), growth factors, adhesion 
molecules, immunoreceptors, and acute-phase proteins (Blackwell et al. 1997). These 
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early response genes are rapidly induced because NF-țB activation does not depend on 
de novo protein synthesis, like AP-1 transcription factors do. In cerebral ischemia, NF-țB
is activated in neurons (Huang et al. 2001;Schneider et al. 1999;Stephenson et al. 
2000;Zhang et al. 2005). Neuronal, but not astrocytic, expression of a NF-țB inhibitor 
reduced both infarct size and cell death 48 hours after permanent median cerebral artery 
occlusion (MCAO) in mice (Zhang et al. 2005). In p50 knockout mice, ischemic damage 
is significantly reduced (Schneider et al. 1999). Activation of NF-țB can be inhibited in 
vivo by treatment with e.g., antioxidants (Stephenson et al. 2000).
In conclusion, due to amongst others compartmentalization and co-activation of a lot of 
different genes, it is difficult to foresee the overall effect of stimulation or inhibition of 
NF-țB on hypoxic-ischemic cell death. 
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Aims of the papers 
Paper I i) Explore whether the detrimental effect of acidosis during   
 reoxygenation is mediated through a deleterious effect on mitochondrial 
function.
ii) Study the effects of hypoxia, reoxygenation and acidosis on
  mitochondrial respiratory complexes. 
iii) Study the timecourse of cell death throughout 21 h
of reoxygenation after 3 h of hypoxia. 
Paper II i) Study the release of cytokines in NT2-N neurons during hypoxia and
  reoxygenation. 
ii) Investigate the effect of acidosis on this cytokine release.
iii) Study the impact of addition of IL-8, MCP-1 and antibodies to these on 
cell death. 
Paper III i) Explore whether hypoxia and reoxygenation in NT2-N neurons change 
  the expression of cytokine receptors and other relevant inflammatory  
  genes. 
ii) Investigate whether acidosis influences this expression.
Paper IV i) Investigate the presence of complement receptor 1 (CD 35), membrane 
  cofactor protein (CD 46), decay accelerating factor (CD 55), protectin (CD 
  59), and complement C3a and C5a receptors (C3aR and C5aR) in human  
  NT2-N neurons.   
  ii) Evaluate the effects of hypoxia-reoxygenation on these proteins. 
iii) Examine the effect of hypoxia-reoxygenation on the C3d-deposition on 
  NT2-N neurons and endothelial cells.  
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Methods
NT2-N neurons 
Upon treatment with retinoic acid (RA), NTera2/clone D1 (NT2) human teratocarcinoma 
cells can be induced to terminally differentiate into postmitotic neuronal cells (NT2-N) 
(Pleasure et al. 1992). Before culturing, the NT2 cells are undifferentiated, without 
markers of astrocytes (GFAP), oligodendrocytes (CNPase), or neurons (MAP-2) (Ferrari 
et al. 2000).
RA is given for 4-5 weeks, mimicking the in vivo situation in which high levels of RA, 
retinoic receptors and RA-binding proteins are found in the embryonic CNS (Horton et 
al. 1995;Rossant et al. 1991). RA initiates expression of neuronal markers resembling 
developing human neurons (Pleasure et al. 1992), induces cholinergic differentiation in a 
subpopulation of NT2 cells (Zeller et al. 1995) and increases apoptosis (Zigova et al. 
2001). Already after 3 days of RA-treatment, the cells show increased expression of 
neurofilament proteins and by 10-14 days processes are observed (Pleasure et al. 1993). 
The cells are replated after the treatment with RA, and judged by the presence of neuron-
specific markers, around 5 % of the cells are now neurons (Pleasure et al. 1992). 2 days 
later, the upper layer of neuronal cells is mechanically dislodged from a bottom layer of 
non-neuronal cells and plated in wells.
The cells receive then mitotic inhibitors for 4 weeks to eliminate non-neuronal cells. This 
treatment has no evident effect on the NT2-N cells, and in the end the culture consists of 
> 95% differentiated NT2-N neurons. The rest of the cells resemble glia cells.  
Morphologically, the NT2-N neurons develop a 
rich network of processes; dendrites containing 
ribosomes and RNA and axons lacking ribosomes. 
They express neuronal markers appropriate for 
human neurons including functional dopaminergic 
(Sodja et al. 2002) and muscarinic acetylcholine 
(Squires et al. 1996) receptors, various voltage-
dependent calcium channels (Neelands et al. 2000) and NMDA and non-NMDA 
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glutamate receptor channels (Hardy et al. 1994;Squires et al. 1996;Younkin et al. 1993). 
While 2-week-old NT2 cells are resistant to glutamate, the 6-week-old NT2-N cells are 
damaged (Hardy et al. 1994;Munir et al. 1995). This gradual increase in sensitivity to 
glutamate, parallels the increased expression of NMDA receptors, resulting in a density 
of approximately 1/10 th of that found in mature rat hippocampal membranes, but 
resembling that found in human neurons (Munir et al. 1995). Recently, the expression of 
large-conductance calcium-activated potassium channels (BKCa) was found (Chapman et 
al. 2007). The cells also have GABAA receptors (Matsuoka et al. 1997), with alteration of 
their receptor function and subunit expression by hypoxic exposure (Gao et al. 2004). 
Finally, the expression of the CNS specific protein Į-internexin, suggests likeness to “late 
embryonic human CNS neurons” (Younkin et al. 1993).  
NT2-N neurons survive, mature and integrate when transplanted into the CNS of rodents 
(Croitoru-Lamoury et al. 2006;Ferrari et al. 2000;Kleppner et al. 1995;Watson et al. 
2003). Positive effects have been demonstrated in animal models of stroke (Borlongan 
1998), brain and spinal cord injury (Saporta et al. 2002;Watson et al. 2003), Parkinson’s 
disease (Baker et al. 2000) and familial amyotrophic lateral sclerosis (Garbuzova-Davis 
et al. 2002). Implantation of NT2-N cells into the human brain in a phase I clinical trial 
for stroke showed that the cells survived for 27 months and did not revert to a neoplastic 
state (Nelson et al. 2002b).
A recent publication showed that a co-culture of NT2-N neuronal and NT2-A astrocytic 
cells was more resistant to toxicity than a NT2-N mono-culture, suggesting that the use of 
astrocytes in an in vitro neurotoxicity test-system may be more relevant to human CNS 
structure and function than neuronal cells alone  (Woehrling et al. 2007). In addition, this 
is an in vitro model with many limitations compared to the in vivo situation (see 
“Discussion”). However, although this system has weaknesses due to the fact that it is a 
neoplastic cell line that is not derived from the brain, it is of human origin, and has been 
widely and successfully used in physiological and pathophysiological studies.
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The hypoxia model 
The hypoxia model was the same for paper I-III and for the 0.1% hypoxia in paper IV. 
The experiments were always started at day three or four after the last change of medium. 
Each well was examined microscopically at least 30 min before use. The different pH 
groups and treatments were randomly placed on the different 12-well plates. 100 IU/mL 
penicillin and 100 μg/mL streptomycin were added to Dulbecco`s modified Eagle 
medium (DMEM) without glucose and the medium was bubbled for 5 minutes with 95% 
N2 and 5% CO2, while heated to 37qC. Immediately before the experiment, the wells 
were washed twice with 0.5 mL phosphate-buffered saline (PBS), and 0.5 mL of 
deoxygenated medium was added to each well.  
The cells were then placed in a preheated, humid anaerobic chamber. Vacuum was 
applied to the chamber for 25 s (20-25 inches of Hg) and the chamber was filled with 
95% N2 and 5% CO2. This procedure was performed four times. Inside the chamber, 
hydrogen was generated with a Gaspak Plus envelope containing a palladium catalyst, to 
remove trace amounts of oxygen. After the last gas exchange, the pressure was confirmed 
using a water lock, and the chamber was placed in an incubator at 37qC for 3 h. We have 
previously shown that these procedures reduce oxygen concentration to 0.1-0.2% after 
the fourth gas exchange, it further decreases to <0.1% within 30-60 min and remains at 
this level thereafter (Rootwelt et al. 1998). We reconfirmed this recently.  
In paper I-III, some experiments were stopped immediately after 3 h of hypoxia, named 
3+0 h. In the remaining experiments, and in paper IV, the medium was removed and new 
medium containing glucose to a final concentration of 5.5 mM/L was added. The cells 
were then returned to the normoxic incubator for 1, 4, 9, or 21 h in paper I, for 3, 6, 12 or 
21 h in paper II and for 21 h in paper III and IV. The experiments were ended with 
aspiration of the supernatants and lysis of the cells. The control groups received exactly 
the same treatment as the hypoxia groups, except that the initial DMEM contained 
glucose before bubbling for 5 min with 21% oxygen and 5% CO2, and that the chamber 
was flushed with 21% oxygen and 5% CO2 after each vacuum. In paper I-III these control 
experiments were terminated at 3+0 h or 3+21 h.
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pH
In our hypoxia-reoxygenation model (Almaas et al. 2003), we are able to separate the 
effects of a treatment given during hypoxia only, from the effects of a treatment given 
during reoxygenation only or during both periods. In paper I, II and III we studied the 
effect that lowering of the pH during either hypoxia and/or reoxygenation had on 
different measurements, using four different experimental pH groups (Table 2). In the 
first paper, HCl was added to adjust pH to 5.9 in the acidotic experiments (Paper I). 
However, we were not fully content with the stability of the pH, as it could vary with 
especially medium batch and bubbling with 95% N2 or 21% oxygen and 5% CO2. In 
paper II and III, we therefore added 10 mM of the buffer PIPES (Piperazine-N,N’-bis[2-
ethanesulfonic acid]) from a 0.8 mM stock and then adjusted pH to 6.1-6.3 in the acidotic 
experiments and to pH 7.4-7.6 in the neutral experiments, by titration with HCl.   
Table 2: Four experimental pH groups, NN, NA, AN and AA, with neutral (N) or 
acidotic (A) medium during hypoxia and/or reoxygenation. 
Biological markers, analyses and imaging techniques  
MTT
To assess cell viability we used an MTT assay, a frequently used method which has been 
shown to correlate well with direct estimates (double staining) of neuronal cell survival in 
NT2-N neurons (Itoh et al. 1998). The soluble yellow tetrazolium dye 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide is intracellularly reduced to an 
insoluble purple product. The formed crystals are dissolved with DMSO and measured 
spectrophotometrically. The reduction of MTT has been shown to occur both inside the 
NN = Neutral medium during hypoxia and Neutral medium during reoxygenation  
NA = Neutral medium during hypoxia and Acidotic medium during reoxygenation  
AN = Acidotic medium during hypoxia and Neutral medium during reoxygenation  
AA = Acidotic medium during hypoxia and Acidotic medium during reoxygenation 
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mitochondria (at coenzyme Q and cytochrome c in the ETC) and outside the 
mitochondria (in endosomes and lysosomes) (Liu et al. 1997).  
Hypoxanthine
Hypoxanthine (Hx) is a breakdown product from ATP. Hx-accumulation is therefore an 
indicator of cellular energy failure (Saugstad 1975;Saugstad 1988). Hx has been shown to 
react abruptly to changes in oxygenation status (Almaas et al. 1997). There is a high 
correlation between ATP depletion and delayed cell death after free radical damage (Aito 
et al. 1999). We found a similar high correlation between Hx and lactate dehydrogenase 
(LDH) release after combined hypoxia and glucose deprivation (paper I and (Almaas et 
al. 2000)). Hx is elevated prior to LDH-release, suggesting that cell membrane disruption 
is not a prerequisite for Hx-accumulation (Rootwelt et al. 1998).  
Lactate dehydrogenase 
LDH is a stable cytoplasmic enzyme present in all cells. It catalyses the interconversion 
of pyruvate and lactate, with concommitant interconversion of NADH and NAD+:
Damage of plasma membrane causes rapid release of LDH. We measured LDH in the 
supernatant and lysate with a colorimetric cytotoxicity detection kit. In the first step, 
NAD+ is reduced to NADH/H+ by the LDH-catalyzed conversion of lactate to pyruvate. 
In the second step, the catalyst (diaphorase) transfers H/H+ from NADH/H+ to the 
tetrazolium salt INT which is reduced to formazan. The amount of colour formed in the 
assay, measured in an ELISA reader at 492 nm with blanks read at 660 nm and 
subtracted, is proportional to the amount of LDH. LDH release in percentage of total 
LDH was calculated as supernatant/(supernatant + lysate). We found that acidosis 
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markedly affected the stability of LDH in the supernatant. Therefore, LDH was only 
measured in the two groups that were neutral during reoxygenation (the NN and AN 
groups). In the current model, LDH release is very well correlated to Hx-measurements 
(paper I) and to the number of dead cells using a viability staining method of hypoxic and 
control cultures (Rootwelt et al. 1998).
Mitochondrial respiratory complexes IV and II + III
We measured the activity of the respiratory complexes IV and II + III to study the effects 
of hypoxia and acidosis and to explore whether the detrimental effect of acidosis during 
reoxygenation was mediated through a deleterious effect on mitochondrial function. Cells 
from three wells were scraped off, and the pellets were frozen at -70qC. The cells were 
later resuspended in ice-cold STE buffer and disrupted with a tight-fitting Teflon-glass 
homogenizer. Enzyme assays were performed at 30qC in a final volume of 0.2 mL, using 
a SPECTRAmax PLUS384 Micro plate Spectrophotometer. COX (complex IV) activity 
was determined by monitoring the initial rate of ferrocytochrome c (200 μM) oxidation at 
the wavelength pair 510-535 nm (Wiedemann et al. 2000) in a medium containing 50 
mM potassium phosphate (pH 7.0) and 0.02 % n-dodecyl-ȕ-D-maltoside. Succinate-
cytochrome c reductase (complex II + III) was measured by following the reduction of 
ferricytochrome c at 550 nm with 580 nm as reference wavelength (Birch-Machin et al. 
2001). Enzyme activities were calculated as nanomoles cytochrome c oxidized (complex 
IV) or reduced (complex II + III) per minute per milligram of cell protein. We also 
calculated the ratio of complex IV/(II + III) to reduce the effect of well to well 
differences, and to demonstrate the different effect of hypoxia-reoxygenation on these 
complexes (Munnich et al. 2001).  
Cytometric bead array
To elucidate the contribution of locally produced cytokines during HI in humans, we used 
cytometric bead array to measure the cytokine-release to the supernatant during hypoxia 
and reoxygenation. The assay principle is briefly as follows: Mixed particles dyed with 
different fluorescence intensities, separately detected by flow cytometry, are coated with 
34 
specific antibodies directed against different analytes. Thus, the different capture beads 
will bind their specific analytes, which then is detected again by free antibodies against 
the same chemokine and conjugated to phycoerythrin. 25ȝL of bead solution was added 
to 25ȝL of sample and then mixed with 25ȝL of a mixture of the corresponding detection 
antibodies. The samples were incubated for 3 h, washed once and resuspended in 50μL 
washing buffer before analysis in a FACS Calibur flow cytometer. All data were 
analyzed using cytometric bead array software. Standard curves were generated for each 
analyte using the mixed analyte standard provided with the kit. The concentration of each 
of the analytes was determined by interpolation from the corresponding standard curve.
Indirect immunofluorescence 
Cells were grown on cover slips with a density of 1 million cells per well in 12-well 
plates. They underwent 3 h of hypoxia and glucose deprivation followed by 15 h of 
reoxygenation. The cells were then washed with PBS and fixed/permeabilized with ice 
cold methanol, followed by washing for 2 x 5 min with PBS containing 0.01% TWEEN 
20 £ (PBST). The cover slips were blocked with PBST containing 2% bovine serum 
albumin (PBST-BSA) for 15 min. Primary antibodies were diluted in PBST-BSA; mouse 
IgG anti-Neurofilament 200 (NF-200, 1:100) together with rabbit anti-human IL-8 (1:50) 
or rabbit anti-human MCP-1 (1:50) and incubated for 30 min. Cells were then washed 3 x 
5 min with PBST-BSA before incubation with fluorochrome-conjugated secondary 
antibodies for 30 min; anti-rabbit-FITC and anti-mouse-TRITC diluted 1:250 in PBST-
BSA. Finally, cells were washed 4 x 5 min in PBST-BSA with 0.5Pg/mL Hoechst added 
in the last wash for DNA staining. The cover slips were mounted in Citifluor AF1 
mounting medium and examined using an Olympus BX61 microscope equipped with an 
F-VIEW digital camera. Photos were acquired on the computer using analySIS£. As 
negative controls the primary antibody was omitted.  
IL-8 and MCP-1 addition 
Recombinant human IL-8 and MCP-1 were reconstituted in deionized water to a final 
concentration of 0.2 mg/ml and 0.16 mg/ml, respectively, as well as antigen-affinity 
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purified polyclonal antibodies, anti-human IL-8 and anti-human MCP-1, both to a final 
concentration of 0.2 mg/ml. All solutions were stored in small aliquots at -20qC.
Recombinant human IL-8 (40, 400 and 4000 ng/mL), recombinant human MCP-1 (400 
and 4000 ng/mL), polyclonal antibody anti-human IL-8 (0.048 μg/mL) or polyclonal 
antibody anti-human MCP-1 (4 μg/mL) were added to both the acidotic and the neutral 
medium before hypoxia. The medium was not changed at the beginning of the 
reoxygenation period lasting 21 h, however, 1% glucose was added to the medium at 
reoxygenation. For these studies we therefore only had two experimental groups, the NN 
and AA group.
TaqMan Low Density Array  
Total RNA was extracted from 3 x 106 cells, quantified using a ND-1000 
spectrophotometer and the RNA quality was analyzed with a Bioanalyzer. Total RNA (18 
–75ng/μl) was reverse transcribed into cDNA employing a cDNA kit (High capacity 
cDNA Archive kit) in a Gene Amp PCR system 9700 thermal cycler. Real-time-PCR was 
performed using pre-coated gene expression TaqMan Low Density Array (TLDA) cards. 
Each card has eight channels (for eight different RNA samples) and each channel 
services 48 wells (in paper III for 24 genes in duplicate). Each card had been previously 
coated and contained the primers for 24 different genes in duplicate including two 
housekeeping genes (peptidylprolyl isomerase A (PPIA) and 18S rRNA). The cDNA was 
diluted and an appropriate amount was mixed with Nuclease-free water and TaqMan 2X 
universal mastermix. The cDNA concentration corresponded to 70-300 ng RNA per 
channel. After applying the cDNA samples, the cards were centrifuged, sealed and loaded 
onto the 7900HT instrument. The 7900HT sequence detection system allows real-time-
PCR quantification of nucleic acids by employing the comparative Ct method of relative 
quantification (RQ). The arithmetic formula for RQ is 2–ǻǻCt, where ǻǻCt is the 
normalized signal level in a sample relative to the normalized signal level in the 
corresponding calibrator sample (Livak et al. 2001).
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Real-time-PCR   
Total RNA from 3 x 106 cells was prepared, the RNA concentration was determined 
using a Nanodrop spectrophotometer and reverse transcribed into cDNA before real-time-
PCR was performed. 10 Șg cDNA for all target genes (CXCR1, CXCR2, CCR1 and 
CCR2) and housekeeping gene (PPIA) was used, employing a SYBR Green PCR Master 
mix in an ABI PRISM 7000 Sequence Detection System. Sample concentrations were 
analyzed employing the same Comparative Ct method of RQ (see above).
Cellular enzyme-linked immunosorbent assay  
A celluar enzyme-linked immunosorbent assay (CELISA) technique was used to 
investigate the presence of CD 35, CD 46, CD 55, CD 59, and C3aR and C5aR on the 
NT2-N neurons. Fixed NT2-N cells were incubated for 60 min with un-conjugated 
antibodies before a secondary antibody (sheep anti-mouse IgG horseradish peroxidase 
linked F(ab’)2) was applied. O-phenylenediamine in citrate buffer was used as a 
peroxidase substrate solution, and the colour reaction was read with a MRX ELISA 
Reader at 490 nm. The cells were subsequently stained with 0.05% crystal violet and a 
nuclear stain eluted in 33% acetic acid before the reading of OD at 540 nm. OD-ratio was 
corrected to the number of cells present in each well. Concentration-matched isotype 
antibodies served as negative controls.
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Summary of results 
Paper I 
Acidosis during reoxygenation has an early detrimental effect on neuronal 
metabolic activity. 
We recently showed that acidosis is protective during hypoxia and detrimental during 
reoxygenation. To study the effects of hypoxia and acidosis on metabolic activity and 
mitochondrial respiratory complexes, human NT2-N neurons were exposed to 3 h of 
hypoxia and glucose deprivation and reoxygenated for 0, 1, 4, 9, or 21 h. Acidotic 
reoxygenation had an early detrimental effect on metabolic activity, shown by a 
significantly higher MTT reduction and a decreased Hx accumulation in cells 
reoxygenated with neutral compared to acidotic medium, both after acidotic hypoxia 
(MTT: p=0.006, Hx: p<0.001 ) and after neutral hypoxia (MTT: p=0.005, Hx: p=0.001). 
During hypoxia and reoxygenation, there was an earlier reduction in the activity of 
complex IV compared to the complexes II+III, and the ratio between these complexes fell 
during the first hour of reoxygenation. The reduction in complex IV activity was 
alleviated with acidotic hypoxia. Acidosis during reoxygenation, however, had no effect 
on the activity of either complex IV or complexes II+III. We concluded that acidosis 
during hypoxia increases neuronal survival and preserves complex IV activity, while 
acidosis during reoxygenation has an early detrimental effect on metabolic activity, but 
this is not mediated through an effect on the mitochondrial complexes IV or II+III.
Paper II
Effect of acidosis on IL-8 and MCP-1 during hypoxia and reoxygenation in human 
NT2-N neurons. 
NT2-N neurons were exposed to 3 h of hypoxia and glucose deprivation and 
reoxygenated for 21 h to study the contribution of locally produced cytokines, the effect 
on cell death of addition of IL-8 and MCP-1 or antibodies to these, as well as the impact 
of acidosis. Compared to controls, both neutral hypoxia (IL-8: p=0.023) and neutral 
reoxygenation (IL-8: p=0.042, MCP-1: p=0.007) led to increased IL-8 and MCP-1 
production. Acidotic compared to neutral hypoxia led to lower IL-8 (p=0.002) and MCP-
1 (p=0.008) levels. Acidosis during reoxygenation, however, significantly increased IL-8 
release, while MCP-1 release was diminished. The cells also secreted RANTES and Ȗ-
interferon-inducible-protein-10 (IP-10), but not any of the 8 other cytokines tested. We 
found no effect on cell death, measured by MTT assay, of addition of IL-8, MCP-1, or 
antibodies to these. We concluded that human NT2-N neurons release IL-8 and MCP-1 
during 21 h of reoxygenation after 3 h of hypoxia. Acidosis during reoxygenation led to a 
differential effect on IL-8 and MCP-1, with increased IL-8 and decreased MCP-1. IL-8 
and MCP-1 had however, no detectable effect on cell death in our model.
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Paper III
Inflammatory receptors and pathways in human NT2-N neurons during hypoxia 
and reoxygenation. Impact of acidosis.  
We studied RNA expression of cytokine receptors and members of inflammatory 
pathways in human NT2-N neurons during 3 h of hypoxia and glucose deprivation 
followed by 21 h of reoxygenation, as well as the impact of acidosis. Right after acidotic 
hypoxia, RNA of IL-10RA and CXCR4 were significantly increased relative to the 
acidotic control, while the anti-apoptotic proteins Bcl-2 and Bcl-xL were significantly 
decreased. After 21 h of neutral reoxygenation after neutral hypoxia, there was a 
significant increase in RNA of CXCR1 (RQ=4.1, p<0.05), CXCR2 (3.6, p<0.05), CCR2 
(3.8, p<0.05), Hsp70 (2.4, p<0.05), HIF-1Į (1.5, p<0.001), TRAF6 (1.3, p<0.05) and 
TNFR1 (1.6, p<0.05). After 21 h of acidotic reoxygenation after acidotic hypoxia, we 
found a significant increase in RNA of IL-1R1, IL-10RA, CXCR4 and Hsp70 compared 
to control, and a significant decrease in FAS and TRAF6 expression. There was a 
significant increase in Bax expression and a significant decrease in Bcl-2 and Bcl-xL 
expression in three out of four pH groups at 21 h of reoxygenation. Acidotic, relative to 
neutral, hypoxia and reoxygenation also influenced the expression of various genes. We 
conclude that inflammatory receptors and pathways are differentially activated during 
hypoxia and reoxygenation in NT2-N neurons, and that this activation is pH dependent. 
Paper IV 
Expression of complement regulators and receptors on human NT2-N neurons - 
effect of hypoxia and reoxygenation. 
By using cellular enzyme-linked immunosorbent assay and immunofluorescence 
microscopy, NT2-N neurons were shown to express significant amounts of proteins of 
CD59 (Clone H19/Clone BRIC229: p<0.001/p<0.001), CD46 (p<0.001), CD55 (p<0.01) 
and C3aR (p<0.001). CD35 and C5aR were not significantly expressed. There was no 
effect of 3 h of 1% hypoxia and 21 h of reoxygenation with 50% AB-serum on any of the 
regulators or receptors. However, CD55 (p=0.02) was down-regulated after 0.1% hypoxia 
and subsequent reoxygenation with AB-serum. No difference in C3d-deposition was 
observed during hypoxia-reoxygenation in neither neurons nor endothelial cells. 
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Discussion
The overall aim for the present work was to understand more about the mechanisms 
behind hypoxic-ischemic brain damage, so that treatment for this important condition 
hopefully can be improved. We focused our research on acidosis, mitochondrial function 
and inflammation, all important but not fully understood phenomena in hypoxic-ischemic 
brain damage and all possibly amendable to interventional treatment.  
When we started with this project, the mechanisms behind the beneficial, protective 
effects during HI of mild to moderate acidosis, which was lost with severe acidosis, were 
discussed. Mitochondria were considered both targets and mediators of the damage 
during HI. Inflammation was thought to play a significant role in perinatally acquired 
brain damage, both as a direct cause and as a contributing mechanism during HI. 
Moreover, complement activation had been shown to cause tissue damage during HI 
through the release of biologically potent activation products and by impaired function of 
regulatory proteins.
Acidosis
Acidosis has diverse and opposing effects on neuronal function and survival. The NT2-N 
hypoxia-reoxygenation model enables us to separate the effects of a treatment given 
during hypoxia only, from the effects obtained with a treatment given during 
reoxygenation only or during both periods. In paper I-III we studied the impact of 
lowering the pH during either hypoxia and/or reoxygenation on cell death. We confirmed 
and extended the previous finding in our lab (Almaas et al. 2003), that the effect of 
acidosis during HI is dependent on timing, as acidosis was protective during hypoxia and 
detrimental during reoxygenation.  
We found that the detrimental effect of acidotic reoxygenation on metabolic activity was 
evident already after 1 h of reoxygenation and that it was maintained during 21 h of 
reoxygenation, as MTT reduction (in percentage of normoxic controls) was significantly 
enhanced  in cells reoxygenated with neutral compared  to acidotic medium, both after 
acidotic and neutral hypoxia. We considered the possibility that acidosis negatively 
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influenced the MTT assay itself, but the cells were washed with buffer before the assay 
and the assay itself was performed in a buffered solution. Furthermore, MTT reduction 
was unaffected by acidosis in the normoxic control experiments. We therefore concluded 
that this was a real effect of acidotic reoxygenation.
This finding of an early detrimental effect of acidosis during reoxygenation makes it 
important to ask the question whether early buffering could be advantageous in the 
treatment after a hypoxic-ischemic insult. A MR spectroscopy study in piglets showed 
that low cerebral pH is a continuous problem throughout 48 h of resuscitation (Penrice et 
al. 1997). Hyperchloremic acidosis induced by HCl infusion significantly reduces MAP 
in normotensive, septic rats (Kellum et al. 2004). However, although a low pH has a 
negative inotropic effect in isolated hearts, the whole-body response in patients is less 
clearly detrimental (Forsythe et al. 2000). It has been postulated that the important 
correlate of successful resuscitation is an improved coronary perfusion and not pH (Kette 
et al. 1990). Also, it is difficult to accurately assess the pH at the cellular level through 
the clinician’s window on acid-base status, the arterial blood pH (Forsythe et al. 2000). A 
Cochrane review on sodium bicarbonate treatment concluded that there is insufficient 
evidence from randomised controlled trials to determine whether infusion of sodium 
bicarbonate reduces mortality and morbidity in infants receiving resuscitation at birth 
(Beveridge et al. 2006). Furthermore, an intravenous infusion of sodium bicarbonate can 
elevate blood pH but may fail to reliably augment the intracellular pH, indeed 
intracellular pH falls in most animal models (Forsythe et al. 2000). This is due to a rise in 
CO2 content when bicarbonate is given, because only CO2 enters into the cells, and not 
bicarbonate. Also, no controlled study has shown an improved hemodynamic state with 
sodium bicarbonate infusion (Forsythe et al. 2000), and it adversely affects cardiac 
resuscitation in pigs (Kette et al. 1991).  The use of sodium bicarbonate infusion during 
resuscitation of newborn is now not recommended (Niermeyer et al. 2000). One could 
therefore speculate whether other buffers with intracellular effects may be more suitable 
during resuscitation. The weak base, Trimethylamine, prevented functional damage in 
isolated rat dorsal spinal roots after hyperglycaemic hypoxia (Euchner-Wamser et al. 
1994). Tris-hydroxymethyl-aminomethane (THAM) combined with mild hypothermia 
was cerebroprotective in rats with acute subdural hematomas (Okauchi et al. 2002). To 
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conclude, although acidosis has a detrimental effect during reoxygenation, there are at 
present no buffers which have been proven effective clinically, and more work has to be 
done.
We further studied the mechanisms behind the differential effect of acidosis. The 
protective effect of acidosis during hypoxia and the detrimental effect during 
reoxygenation were confirmed by MTT measurements, hypoxanthine accumulation and 
LDH release. NMDA receptor stimulation is central to hypoxic cell death in our model 
(Almaas et al. 2000;Almaas et al. 2002;Almaas et al. 2003;Rootwelt et al. 1998) and 
blockade of NMDA receptors confers no added protection compared to that given by 
acidosis alone (Almaas et al. 2003). We can therefore conclude that the protective effect 
of acidosis during hypoxia to a large extent is mediated through inhibition of NMDA 
receptor-mediated damage (Almaas et al. 2003;Froyland et al. 2005;Giffard et al. 
1990;Tombaugh et al. 1990).  
A possible aggravating effect of acidosis during reoxygenation, as postulated in paper I, 
could be mediated through a deleterious effect on mitochondrial function. We found an 
early detrimental effect on MTT reduction and a progressive accumulation of 
hypoxanthine with acidotic reoxygenation, suggesting impaired mitochondrial function 
due to acidosis. However, MTT reduction is not specific for mitochondrial function, as 
some reduction may occur in living cells outside the mitochondria (Berridge et al. 
1993;Liu et al. 1997). Furthermore, the pH-level during reoxygenation did not 
significantly affect the activities of complex II+III or IV, and changes in complex II+III 
and IV could therefore not explain the detrimental effects of acidosis during 
reoxygenation. Another possible aggravating effect of acidosis during reoxygenation 
could be an increase in free radical formation (Almaas et al. 2003;Siesjo et al. 1985), but 
we have not found oxygen radicals to be an important mediator of cell death in our model 
(Almaas et al. 2002). To conclude, acidosis during reoxygenation has a detrimental effect 
on metabolic activity, which may be mediated through a deleterious effect on 
mitochondrial function, although we were not able to demonstrate a specific 
mitochondrial effect of acidosis. 
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Mitochondrial function 
Complex IV activity was affected earlier by hypoxia and reoxygenation than complex 
II+III. This was confirmed by calculating the ratio of complex IV to complex II+III 
(Munnich et al. 2001). This is in accordance with the findings of an early onset and a 
progressive reduction in the partly mitochondrial DNA encoded complex IV mRNA and 
activity, in contrast to a more stable nuclear DNA encoded complex II (Abe et al. 1995). 
Other animal studies have also found an early decrease of complex IV activity (Dimlich 
et al. 1990;Nelson et al. 1994). This early onset and progressive disturbance of complex 
IV activity may contribute to the failure of energy production, i.e. the secondary energy 
failure observed in animal and clinical studies (Iwata et al. 2007;Lorek et al. 
1994;Northington et al. 2001b).
We have previously shown that a combination of energy failure and glutamate 
stimulation is toxic to NT2-N neurons (Rootwelt et al. 1998). After 21 h of 
reoxygenation, we detected a reduction in complex IV comparable to the level that 
previously has been shown to impair ATP production, as complex I, III, and IV activities 
in brain mitochondria had to decrease by approximately 25%, 80%, and 70%, 
respectively, before major changes in oxygen consumption and ATP synthesis occurred 
(Davey et al. 1998). However, the reduction at previous time points was more modest and 
by itself not enough to explain the observed changes in energy status. It is therefore still 
unclear whether the decline in mitochondrial function after HI in this and other studies 
contributes to the final neuronal damage, or if it is a secondary event in the 
developmental injury (Wagner et al. 1990a). Irrespectively, the early influence on 
complex IV is of importance since treatment started in this “therapeutic time window” 
after HI might reduce the damage.  
Inflammation
There is growing evidence that inflammation plays a significant role in perinatally 
acquired brain damage, both as a direct cause and as a contributing mechanism during HI 
(Hagberg et al., 2002), in both preterm and term infants (Ferriero, 2004). Furthermore, 
both animal experiments and epidemiological studies indicate that if the perinatal brain is 
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exposed to both inflammation and HI, the damaging effect increases markedly (Eklind et 
al., 2001; Kendall and Peebles, 2005; Nelson and Grether, 1998).  
Although cytokines are predominantly produced by cells of the immune system, it has 
been postulated that brain cells can contribute to inflammation in response to brain injury 
by producing chemokines in situ (Cai et al. 2000;Kadhim et al. 2001), and, since they 
carry receptors, also respond to inflammatory cytokines produced either by cells in the 
CNS or transported into the CNS from the periphery. NT2-N neurons have previously 
been shown to constitutively release MCP-1 (Coughlan et al., 2000). We confirmed and 
advanced this finding in paper II. During hypoxia and reoxygenation production of the 
chemokines MCP-1, IL-8 and RANTES was markedly increased, while IP-10 was 
unaffected by hypoxia. These findings are in accordance with a recent study of human 
preterm infants which showed IL-8 to be significantly higher in CSF than in plasma, both 
in infants with and without white matter injury, showing that locally produced IL-8 
contributes significantly to CNS IL-8 levels (Ellison et al. 2005). Also, increased 
production of IL-8 has been demonstrated after hypoxia in granulosa-lutein cells from 
human ovarian follicles (Yoshino et al. 2003) and in human monocyte derived 
macrophages (Hirani et al. 2001). However, neither Lu et al nor Coughlan et al detected
release of IL-8 from unstimulated NT2-N neurons (Coughlan et al. 2000;Lu et al. 2005), 
using different sensitivity and cell density, respectively. However, by using in situ
hybridization and immunohistochemistry, Bakhiet et al found low levels of cytokines in 
unstimulated human foetal astrocytes and neurons, and that in the presence of LPS and 
other inflammatory mediators, both astrocytes and neurons were major sources of IL-8, 
MCP-1, MIP-1Į, MIP-1ȕ and RANTES (Bakhiet et al. 2002). Studies with asphyxia or 
HI have showed an increase in IL-1ȕ, TNF-Į, IL-6, IL-18 and MIP-1Į in rat brain tissue 
(Bona et al. 1999;Cowell et al. 2002;Hagberg et al. 1996;Hedtjarn et al. 2002) and high 
levels of cytokines in newborn infants; e.g. IL-6 and TNF- Į in CSF (Silveira et al. 2003) 
and IL-6, IL-8 and RANTES in plasma (Shalak et al. 2002a;Silveira et al. 2003).
We further found that IL-8 and MCP-1 were affected by acidosis, while RANTES and 
IP-10 were unaffected. Acidosis during hypoxia was associated with lower IL-8 and 
MCP-1 levels and reduced damage. In contrast, acidosis during reoxygenation was 
associated with higher IL-8 levels but lower MCP-1 levels and increased damage (paper 
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II). This differential effect of acidosis during reoxygenation may be related to the fact 
that these two inflammatory mediators belong to two different families of chemokines, 
and therefore are regulated differentially. Acidosis during normoxia has previously been 
shown to stimulate IL-8 production in astrocytes, but not in neurons (Watanabe et al. 
1998).
We found, however, no significant effect on cell death, measured by MTT assay, of 
addition of recombinant IL-8, MCP-1, anti-human IL-8 or anti-human MCP-1. This is in 
contrast with Matsumoto et al, who found significant reduction of brain edema and 
infarct size after treatment with a neutralizing anti-IL-8 antibody in an in vivo rabbit 
model of transient focal ischemia (Matsumoto et al. 1997). Previous studies have given 
conflicting results concerning the effect of MCP-1 on neuronal death, as both protection 
from NMDA-induced apoptosis (Eugenin et al. 2003) and increased apoptosis (Kalehua 
et al. 2004) have been reported. An explanation for the lack of effects in our model could 
be that cytokine production reflects a response to, rather than active involvement in, 
neurodegeneration (Allan et al. 2001). Also, when administrated separately, cytokines 
tend not to evoke cell death directly (Allan et al. 2001). Finally, cell-culture systems 
usually comprise immature cells. They are an isolated system and lack e.g. glia, 
endothelia, white cells and synaptic connections that might be essential for cytokine 
action (Allan et al. 2001).
By binding to different receptors on target cells, cytokines act differently and cause, 
exacerbate, mediate and/or inhibit cellular injury and repair (Allan et al. 2001). We 
therefore extended our study to include cytokine receptors, other inflammatory receptors 
and their downstream inflammatory genes in paper III. NT2-N neurons have previously 
been shown to constitutively express receptors for IL-8 (CXCR1 and CXCR2, Coughlan 
et al., 2000; Lu et al., 2005), MCP-1 (CCR2, Coughlan et al., 2000) and RANTES 
(CCR1, Valerio et al., 2004). We confirmed and extended these findings. During hypoxia 
and reoxygenation we further presented data on the expression of the receptors CXCR1, 
CXCR2, CXCR4, CCR1, CCR2, IL-1R1, IL-6R, IL-10RA and TNFR1, in addition to the 
expression of Bax, Bcl-2, Bcl-xL, FAS, Hsp70, HIF-1alpha, GLUT1 and TRAF6 (paper 
III). Hypoxia, reoxygenation and acidosis were found to influence the expression of these 
receptors and their downstream inflammatory genes. We first studied receptors for 
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interleukins and found an increased expression of IL-1R1, IL-6R and IL-10RA after 21 h 
of reoxygenation. This is in accordance with previous findings in rats where increased 
mRNA for IL-1R was found after HI (Wang et al. 1997). Up-regulation of IL-6 (the 
ligand; not the receptor) is seen in the hippocampus after kainic acid-induced seizures 
and in the striatum between 4 and 24 h after a mechanical lesion (Lehtimaki et al. 
2003;Thier et al. 1999). Furthermore, a reduction in the number of apoptotic cells is 
observed after addition of recombinant IL-10 to cerebellar granule cells together with or 
1 h after glutamate (Bachis et al. 2001). These results suggest that IL-1R1 and IL-6R are 
important for the progressive neurodegeneration that ensues subsequent to a mild HI 
injury, while in our study, the increase in IL-10RA during acidotic hypoxia-
reoxygenation may be a protective mechanism.  
We did not detect expression of the cytokine receptors CXCR1, CXCR2, CCR1 or CCR2 
in the NT2-N neurons with the TLDA assay. However, these receptors were detected 
with a manual quantitative real-time PCR, that was carefully set up in regard to the 
choice of primer sequences, primer concentrations and amount of template used. Under 
neutral conditions we found hypoxia to increase the amount of these receptors, but we did 
not detect any significant pH-effect. CXCR4 increased in accordance with previous 
studies showing transient up-regulation of CXCR4 in response to HI in cerebral mice 
cortical neurons (Stumm et al. 2002) and in rat penumbra-like areas (Felszeghy et al. 
2004).
After 21 h of reoxygenation we found a significant increase in the proapoptotic Bax and a 
significant decrease in the antiapoptotic Bcl-2 and Bcl-xL in the three pH groups (NA, 
NN and AA) which in this model show most damage (Almaas et al. 2003;Froyland et al. 
2005). This gave a similar increase in the Bax-to-Bcl-2 ratio as a previous study on focal 
cerebral ischemia in mice (Matsushita et al. 1998), following  MCA occlusion in rats 
(Gillardon et al. 1996) as well as in cell cultures of the neocortex subjected to prolonged 
hypoxia (Tamatani et al. 1998). Apoptotic mechanisms have, however, previously been 
shown to play a minor role after oxygen and glucose deprivation in our model (Almaas et 
al. 2003), and the implications of these findings for the cell death observed in our model 
are therefore uncertain.  
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We also detected the expression of FAS, TNFR1 and TRAF6. In accordance with 
previous findings of increased Fas protein expression in neonatal rat brain after HI 
(Felderhoff-Mueser et al. 2000;Northington et al. 2001a), we found increased expression 
of FAS after 21 h of reoxygenation. However, we do not have any good explanations for 
the significant increase only seen in the most protected (AN) group, while models of HI 
both in rats and neonatal mice showed neuroprotection of a lack of functional FAS 
(Martin-Villalba et al. 1999;Rosenbaum et al. 2000). Studies on TNF-Į have detected 
both a protective role, as neuronal damage after focal ischemia-reperfusion is 
significantly increased in mice lacking TNFR1 receptors compared with wt-mice (Gary et 
al. 1998), as well as a detrimental role, as TNF binding protein was neuroprotective in 
focal cerebral ischemia in mice (Nawashiro et al. 1997). Previous studies on TNFR1 and 
TNFR2 have shown induction of both of these receptors after ischemia in e.g. rat and 
human neurons (Botchkina et al. 1997;Dziewulska et al. 2003), while we only detected 
TNFR1, being significantly increased in the most damaged groups after 21 h of 
reoxygenation. We detected a marked increase in RNA for Hsp70 during acidotic 
hypoxia. This may contribute to the protective effect of acidosis during hypoxia seen in 
our model, as over-expression of Hsp70 has been shown to provide neuroprotection 
against cerebral ischemia both in vitro (Kelly et al. 2001;Lee et al. 2001) and in vivo 
(Matsumori et al. 2005;Rajdev et al. 2000;Tsuchiya et al. 2003). HIF-1Į was significantly 
increased compared to controls following 21 h of reoxygenation in the two most damaged 
groups, while acidosis during either hypoxia or reoxygenation led to a decrease in HIF-1Į
after 21 h of reoxygenation. Previously, inconsistent effects of acidosis on HIF-1Į protein 
and its target genes have been found, suggesting yet undefined pH-sensitive factors to be 
involved in the regulation of these genes (Willam et al. 2006).  
Interpretation of cell death and inflammation in an in vitro model is difficult due to an 
isolated system of usually immature neuronal cells that lacks e.g. glia, endothelial cells, 
white cells and extensive synaptic connections that may be essential for cytokine action 
(Allan et al. 2001). Also, changes in cytokines of both protective and damaging character 
occur, which together affect the final cell death. We found no effect on cell death of 
addition of IL-8, MCP-1 or antibodies to these in our NT2-N model (paper II). 
Explanations for the lack of effects in our model as mentioned above could be that 
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cytokine production reflects a response to, rather than active involvement in, 
neurodegeneration, and that when administrated separately, cytokines tend not to evoke 
cell death directly (Allan et al. 2001). This illuminates the fact that testing in a pure 
neuronal system only will not give all relevant information. 
However, we have shown that neurons clearly play a part in the production of cytokines 
and that they express the relevant receptors. In addition, we have described the influence 
of hypoxia, reoxygenation and acidosis on cytokine production and receptor expression. 
Other studies have shown that this interplay can affect the extent of cell death. However, 
the system is quite complex with many different players, and includes additional
important actors in vivo. Still, these pathways represent important pharmacological 
targets.  
In paper IV, we demonstrated for the first time the expression of complement regulatory 
proteins and receptors on human NT2-N neurons, as these cells constitutively expressed 
C3aR, CD46, CD 55 and extensive amounts of CD59, but no C5aR or CD35  (Pedersen 
et al. 2007). CD59, which protects the cell against sublytic stimulation and cell lysis by 
inhibiting the insertion of membrane-attack complexes, has previously been found in a 
human neuroblastoma cell line (Cole et al. 2006), fetal human neuronal cells (Singhrao et 
al. 2000) and cerebellar Purkinje cells (Storstein et al. 2004). Loss of CD59 probably 
increases the susceptibility of the cells to complement-mediated injury, as found in 
damaged tissue after myocardial infarction (Vakeva et al. 2000). It is reasonable to 
suggest a role for CD59 in protecting the brain during a stroke, since CD59 deficiency 
leads to enhanced tissue damage in experimental autoimmune encephalomyelitis (Mead 
et al. 2004) and ischemia-reperfusion injury in mice (Turnberg et al. 2004).
Although we found no effect of hypoxia and reoxygenation on CD59 expression (our in
vitro data do therefore not support the importance of loss of CD59 for ischemia-
reperfusion), the loss of this regulator may have serious consequences for cell survival in
vivo. We found a slight down-regulation of CD55 after severe hypoxia with 0.1% 
oxygen, which may render the cells more susceptible to complement damage, and 
thereby, contribute to brain tissue damage during a stroke. Although we found the NT2-N 
cells to express substantial amounts of C3aR (anaphylatoxin), which previously has also 
been shown to play a considerable role in the development of experimental autoimmune 
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encephalomyelitis (Boos et al. 2004), the role of C3aR receptors in the case of a stroke, 
still remains unclear and needs to be further investigated.
To conclude, the mechanisms for HI damage and its effectors are very complex. We have 
studied some of them. Many of these can be important, but we have not found any single 
factor that can be targeted in clinical practice at present. Research on hypothermia shows 
that the mechanisms and cascades responsible for delayed energy failure and cell death 
develops in the first hours after the insult. Hypothermia is now used as a treatment for 
asphyxiated full-term newborns, hopefully prolonging the “therapeutic time window” and 
improving prognosis. Most likely, we need a combination of different treatments. These 
should be tested both in vivo and in isolated cell-culture systems.  
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Conclusions
Paper I i) The detrimental effect of acidosis during reoxygenation was not 
mediated by an effect on complex II+III or IV.  
ii) Complex IV activity was affected earlier by hypoxia and reoxygenation 
  than complex II+III. Whereas acidosis during hypoxia preserved complex 
  IV activity, pH during reoxygenation did not significantly affect the
  activities of complexes II+III and IV.  
iii) Acidotic reoxygenation was found to have an early detrimental effect 
on metabolic activity, measured as MTT reduction, and to cause an 
increased accumulation of Hx.  
Paper II i) During 21 h of reoxygenation after 3 h of hypoxia, human NT2-N 
neurons released IL-8, MCP-1, RANTES and IP-10, but none of the 8 
other cytokines tested.
ii) Acidosis led to a differential effect on IL-8 and MCP-1, with increased 
 IL-8 and decreased MCP-1, both during reoxygenation and in normoxic  
 controls.  
iii) Addition of IL-8, MCP-1 or antibodies to these during hypoxia and
 reoxygenation had no apparent effect on cell death. This lack of effect was 
seen both with acidosis and with neutral medium.
Paper III i) Cytokine receptors and other relevant inflammatory genes were 
differentially activated during hypoxia and reoxygenation.
ii) This differential activation was pH dependent.
Paper IV i) Human NT2-N neurons constitutively expressed C3aR, CD 46, CD 55 
and, in particular, CD 59.
ii) Severe hypoxia-reoxygenation down-regulated CD 55 expression, while 
the other proteins were not affected.
  iii) Hypoxia-reoxygenation did not influence C3d-deposition.
Erratum
Figures 1 and 3 appearing in article I, “Acidosis during reoxygenation has an early 
detrimental effect on neuronal metabolic activity”, were not typeset correctly. The correct 
figures appear below. 
       
     Fig. 1                                   Fig. 3  
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